tiprankstipranks
Whitehawk Therapeutics (WHWK)
NASDAQ:WHWK
US Market
WHWK
Whitehawk Therapeutics
RESEARCH TOOLSreports
Want to see WHWK full AI Analyst Report?

Whitehawk Therapeutics (WHWK) Income Statement

501 Followers

Whitehawk Therapeutics Income Statement

Last quarter (Q4 2025), Whitehawk Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Whitehawk Therapeutics's net income was $-23.25M. See Whitehawk Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.14M$ 25.98M$ 24.35M$ 15.22M$ 1.12M
Gross Profit
$ 6.38M$ -28.07M$ -27.38M$ -18.78M$ -18.55M
Operating Expenses
$ 120.78M$ 39.39M$ 44.55M$ 43.90M$ 92.67M
Depreciation and Amortization
$ 0.00$ 193.00K$ 169.00K$ 159.00K$ 105.00K
EBITDA
$ -114.40M$ -64.63M$ -71.76M$ -58.80M$ -36.96M
Operating Income
$ -114.40M$ -67.46M$ -71.93M$ -62.68M$ -111.22M
Other Income/Expenses
$ 93.80M$ 3.77M$ 6.17M$ 2.17M$ 1.13M
Pretax Income
$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
Net Income
$ -20.60M$ -63.69M$ -65.77M$ -60.51M$ -110.09M
Per Share Metrics
Basic EPS
$ -0.33$ -2.36$ -2.44$ -2.69$ -12.41
Diluted EPS
$ -0.33$ -2.36$ -2.44$ -2.69$ -12.41
Weighted Average Shares Outstanding
 61.89M 27.03M 26.92M 22.51M 8.87M
Weighted Average Shares Outstanding (Diluted)
 61.89M 27.03M 26.92M 22.51M 8.92M
Currency in USD

Whitehawk Therapeutics Earnings and Revenue History